These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 36129018)

  • 41. Electrostatic Interactions Are the Primary Determinant of the Binding Affinity of SARS-CoV-2 Spike RBD to ACE2: A Computational Case Study of Omicron Variants.
    Sang P; Chen YQ; Liu MT; Wang YT; Yue T; Li Y; Yin YR; Yang LQ
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular dynamics simulations of the SARS-CoV-2 Spike protein and variants of concern: structural evidence for convergent adaptive evolution.
    Neto DFL; Fonseca V; Jesus R; Dutra LH; Portela LMO; Freitas C; Fillizola E; Soares B; Abreu AL; Twiari S; Azevedo V; Goes-Neto A; de Medeiros AC; Lopes NP; Zanotto PMA; Kato RB
    J Biomol Struct Dyn; 2023; 41(12):5789-5801. PubMed ID: 35848330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Key Interacting Residues between RBD of SARS-CoV-2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation.
    Jawad B; Adhikari P; Podgornik R; Ching WY
    J Chem Inf Model; 2021 Sep; 61(9):4425-4441. PubMed ID: 34428371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural and functional insights into the major mutations of SARS-CoV-2 Spike RBD and its interaction with human ACE2 receptor.
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM; Al-Hemaid F; Sami H
    J King Saud Univ Sci; 2022 Feb; 34(2):101773. PubMed ID: 34955621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urtica dioica agglutinin (UDA) as a potential candidate for inhibition of SARS-CoV-2 Omicron variants: In silico prediction and experimental validation.
    Sabzian-Molaei F; Hosseini S; Alipour A; Ghaderi H; Fotouhi-Chahouki F; Hadi A; Shahsavarani H
    Phytomedicine; 2023 Mar; 111():154648. PubMed ID: 36681052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deciphering the mechanism of resistance by novel double mutations in pncA in Mycobacterium tuberculosis using protein structural graphs (PSG) and structural bioinformatic approaches.
    Alshabrmi FM; Alatawi EA
    Comput Biol Med; 2023 Mar; 154():106599. PubMed ID: 36731361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel consensus-based computational pipeline for screening of antibody therapeutics for efficacy against SARS-CoV-2 variants of concern including Omicron variant.
    Kumar N; Kaushik R; Zhang KYJ; Uversky VN; Sahu U; Sood R; Bhatia S
    Proteins; 2023 Jun; 91(6):798-806. PubMed ID: 36629264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atomistic insights into the binding of SARS-CoV-2 spike receptor binding domain with the human ACE2 receptor: The importance of residue 493.
    Carter C; Airas J; Parish CA
    J Mol Graph Model; 2023 Jan; 118():108360. PubMed ID: 36401897
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probing the binding nature and stability of highly transmissible mutated variant alpha to omicron of SARS-CoV-2 RBD with ACE2 via molecular dynamics simulation.
    Ramakrishnan J; Chinnamadhu A; Suresh S; Poomani K
    J Cell Biochem; 2023 Aug; 124(8):1115-1134. PubMed ID: 37435893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Silico Analysis of Bacteriocins from Lactic Acid Bacteria Against SARS-CoV-2.
    Erol I; Kotil SE; Fidan O; Yetiman AE; Durdagi S; Ortakci F
    Probiotics Antimicrob Proteins; 2023 Feb; 15(1):17-29. PubMed ID: 34837166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection.
    Chen RH; Yang LJ; Hamdoun S; Chung SK; Lam CW; Zhang KX; Guo X; Xia C; Law BYK; Wong VKW
    Front Pharmacol; 2021; 12():634176. PubMed ID: 33897423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insights from computational analysis: how does the SARS-CoV-2 Delta (B.1.617.2) variant hijack ACE2 more effectively?
    Xiong D; Zhao X; Luo S; Duan L
    Phys Chem Chem Phys; 2022 Apr; 24(15):8683-8694. PubMed ID: 35364605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural insights into the effect of mutations in the spike protein of SARS-CoV-2 on the binding with human furin protein.
    Suleman M; Luqman M; Wei DQ; Ali S; Ali SS; Khan A; Khan H; Ali Z; Khan W; Rizwan M; Ullah N
    Heliyon; 2023 Apr; 9(4):e15083. PubMed ID: 37064465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer.
    Bharathi M; Sivamaruthi BS; Kesika P; Thangaleela S; Chaiyasut C
    Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy.
    Ridgway H; Chasapis CT; Kelaidonis K; Ligielli I; Moore GJ; Gadanec LK; Zulli A; Apostolopoulos V; Mavromoustakos T; Matsoukas JM
    Viruses; 2022 May; 14(5):. PubMed ID: 35632769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2.
    Chen X; Wang Z; Wang J; Yao Y; Wang Q; Huang J; Xiang X; Zhou Y; Xue Y; Li Y; Gao X; Wang L; Chu M; Wang Y
    Front Pharmacol; 2022; 13():940628. PubMed ID: 36003511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
    Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Corilagin and 1,3,6-Tri-
    Binette V; Côté S; Haddad M; Nguyen PT; Bélanger S; Bourgault S; Ramassamy C; Gaudreault R; Mousseau N
    Phys Chem Chem Phys; 2021 Jul; 23(27):14873-14888. PubMed ID: 34223589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Probing Mechanisms of Binding and Allostery in the SARS-CoV-2 Spike Omicron Variant Complexes with the Host Receptor: Revealing Functional Roles of the Binding Hotspots in Mediating Epistatic Effects and Communication with Allosteric Pockets.
    Verkhivker G; Agajanian S; Kassab R; Krishnan K
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.